JPS548674B2 - - Google Patents

Info

Publication number
JPS548674B2
JPS548674B2 JP11655175A JP11655175A JPS548674B2 JP S548674 B2 JPS548674 B2 JP S548674B2 JP 11655175 A JP11655175 A JP 11655175A JP 11655175 A JP11655175 A JP 11655175A JP S548674 B2 JPS548674 B2 JP S548674B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11655175A
Other languages
Japanese (ja)
Other versions
JPS5212156A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5212156A publication Critical patent/JPS5212156A/ja
Publication of JPS548674B2 publication Critical patent/JPS548674B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0044—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50116551A 1974-10-01 1975-09-29 Production of androstanic cyclopentanophenanthrene compound Granted JPS5212156A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT27968/74A IT1054189B (it) 1974-10-01 1974-10-01 2 carbossiandrosta 1.j dien 3 oni e loro derivati

Publications (2)

Publication Number Publication Date
JPS5212156A JPS5212156A (en) 1977-01-29
JPS548674B2 true JPS548674B2 (de) 1979-04-17

Family

ID=11222700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50116551A Granted JPS5212156A (en) 1974-10-01 1975-09-29 Production of androstanic cyclopentanophenanthrene compound

Country Status (5)

Country Link
JP (1) JPS5212156A (de)
DE (1) DE2543521C3 (de)
FR (1) FR2286653A1 (de)
GB (1) GB1519215A (de)
IT (1) IT1054189B (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062843A (en) * 1960-01-06 1962-11-06 Syntex Corp C-2-carboxylic acid and c-2-hydroxymethyl derivatives of the androstane series

Also Published As

Publication number Publication date
JPS5212156A (en) 1977-01-29
DE2543521A1 (de) 1976-04-15
GB1519215A (en) 1978-07-26
FR2286653B1 (de) 1978-07-28
FR2286653A1 (fr) 1976-04-30
IT1054189B (it) 1981-11-10
DE2543521B2 (de) 1977-10-13
DE2543521C3 (de) 1978-06-01

Similar Documents

Publication Publication Date Title
AU7459574A (de)
FR2286653B1 (de)
AU7237274A (de)
CH577851A5 (de)
CH577664A5 (de)
BE836685A (de)
BG19998A1 (de)
BG20232A1 (de)
BG20660A1 (de)
BG20884A1 (de)
BG21102A1 (de)
BG21248A1 (de)
BG21276A1 (de)
BG21335A1 (de)
BG21431A1 (de)
BG21479A1 (de)
BG21781A1 (de)
BG22868A1 (de)
BG23080A1 (de)
BG26382A4 (de)
BG26532A3 (de)
BG27086A3 (de)
CH563933A5 (de)
CH569111A5 (de)
CH570749A5 (de)